The Pink Fund provides financial assistance to breast cancer victims to ease their financial stress.
The Danish pharmaceuticals maker is facing tighter margins and tougher competition in the U.S.
As consumer confidence and health care spending soar, Johnson & Johnson is becoming one of the best total return packages available.
This pharmaceutical giant has struggled in recent years but is wisely repositioning itself as the world's largest manufacturer of vaccines.
Here is a look at two big pharma stalwarts to determine the better stock to buy for growth and income.
Analysts are predicting that the legal pot market could reach $6.7 billion in sales this year.
Debate switches futures into positive territory after down day on Wall Street.
Attacking Big Pharma price gougers may be all that unifies the candidates ahead of tonight's debate.
Driving sector performance are a recent series of mergers and acquisitions, including Horizon Pharma's purchase of Raptor Pharmaceutical Corp. Then there's the political boost...
Failure is very profitable for Pain Therapeutics CEO Remi Barbier.